''Glitazones'', a prospect for non-insulin-dependent diabetes

被引:15
作者
Petrie, J [1 ]
Small, M [1 ]
Connell, J [1 ]
机构
[1] W GLASGOW HOSP UNIV NHS TRUST,GLASGOW,LANARK,SCOTLAND
关键词
D O I
10.1016/S0140-6736(97)22002-7
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
引用
收藏
页码:70 / 71
页数:2
相关论文
共 11 条
[1]   Appraisal of effectiveness and potential therapeutic benefit of acarbose: A non-consensus conference [J].
Berger, M ;
Kobberling, J ;
Windeler, J .
DIABETOLOGIA, 1996, 39 (07) :873-874
[2]   PATHOGENESIS OF NIDDM - A BALANCED OVERVIEW [J].
DEFRONZO, RA ;
BONADONNA, RC ;
FERRANNINI, E .
DIABETES CARE, 1992, 15 (03) :318-368
[3]  
IBRAHIMI A, 1994, MOL PHARMACOL, V46, P1070
[4]  
Iwamoto Y, 1996, DIABETIC MED, V13, P365, DOI 10.1002/(SICI)1096-9136(199604)13:4<365::AID-DIA19>3.0.CO
[5]  
2-M
[6]   IMPROVEMENT IN GLUCOSE-TOLERANCE AND INSULIN-RESISTANCE IN OBESE SUBJECTS TREATED WITH TROGLITAZONE [J].
NOLAN, JJ ;
LUDVIK, B ;
BEERDSEN, P ;
JOYCE, M ;
OLEFSKY, J .
NEW ENGLAND JOURNAL OF MEDICINE, 1994, 331 (18) :1188-1193
[7]   MEASUREMENT OF PROINSULIN AND INTERMEDIATES - VALIDATION OF IMMUNOASSAY METHODS BY HIGH-PERFORMANCE LIQUID-CHROMATOGRAPHY [J].
OSTREGA, D ;
POLONSKY, K ;
NAGI, D ;
YUDKIN, J ;
COX, LJ ;
CLARK, PMS ;
HALES, CN .
DIABETES, 1995, 44 (04) :437-440
[8]   NEW PHARMACOLOGICAL APPROACHES TO INSULIN AND LIPID-METABOLISM [J].
PETRIE, JR ;
DONNELLY, R .
DRUGS, 1994, 47 (05) :701-710
[9]   The peroxisome proliferator activated receptors (PPARs) and their effects on lipid metabolism and adipocyte differentiation [J].
Schoonjans, K ;
Staels, B ;
Auwerx, J .
BIOCHIMICA ET BIOPHYSICA ACTA-LIPIDS AND LIPID METABOLISM, 1996, 1302 (02) :93-109
[10]   ACTIONS OF NOVEL ANTIDIABETIC AGENT ENGLITAZONE IN HYPERGLYCEMIC HYPERINSULINEMIC OB/OB MICE [J].
STEVENSON, RW ;
HUTSON, NJ ;
KRUPP, MN ;
VOLKMANN, RA ;
HOLLAND, GF ;
EGGLER, JF ;
CLARK, DA ;
MCPHERSON, RK ;
HALL, KL ;
DANBURY, BH ;
GIBBS, EM ;
KREUTTER, DK .
DIABETES, 1990, 39 (10) :1218-1227